Sparrow Link device for opioid withdrawal in hospital
Part of Mental health clinical trials.
This trial tests a device placed on the ear to help manage opioid withdrawal symptoms in hospitalized adults. It's for people still having withdrawal despite standard medications or those who've chosen not to take methadone or buprenorphine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with opioid use disorder or have a history of active opioid use.
- You are currently having mild to moderate opioid withdrawal symptoms (based on a standard symptom scale).
- Your withdrawal is not fully controlled by methadone, buprenorphine, or other medications, OR you are tapering off full agonists, OR you declined methadone or buprenorphine but need help with withdrawal or pain.
- You do not have a history of seizures or an active seizure disorder.
- You do not have a pacemaker, defibrillator, or other implanted nerve stimulator.
- You are not pregnant or breastfeeding.
- You do not have a serious ear infection, skin problem at the electrode site, or abnormal ear anatomy.
- You do not have an active neurological condition like brain injury, stroke, or multiple sclerosis.
- You do not have severe alcohol or benzodiazepine withdrawal that is not controlled by medication.
- You are not allergic to hydrocolloid adhesive bandages.
- You do not have active psychosis.
- You are able to speak and understand English well enough to give informed consent and complete study assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors to track physical signs of opioid withdrawal and cravings over 14 days. It aims to better understand these symptoms in people currently taking or planning to start medication for opioid use disorder.
This study tests whether a device that stimulates the ear (through the skin) can reduce chronic pain and help people lower their opioid pain medicine. It may help you manage pain with less opioid use if you meet their safety and medication criteria.
This trial tests whether a single treatment with ibogaine, a plant-based medicine, combined with a year of app and wearable support, helps people reduce or stop opioid use. It is for adults who have not had success with other treatments and are seeking a new option.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This study is testing whether adding a medication (buprenorphine), counseling, and a type of brain stimulation (TMS) can improve long-term opioid therapy for chronic pain. If you have been taking prescription opioids daily for at least 3 months and have extra risk factors for opioid-related problems, this trial may offer you new ways to manage pain and reduce risks.
This trial tests a reward-based program (contingency management) to help inpatients with opioid use disorder stay in treatment and avoid drug use. It may help by providing incentives for attending sessions and testing clean.
Hear when a new Opioid Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.